Skip to content

Immunogenicity and safety COVID-19 vaccine in healthy adults: a single institute based cohort study

Immunogenicity and safety COVID-19 vaccine in healthy adults: a single institute based cohort study - Immunogenicity and safety of COVID-19 vaccine in healthy adults

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043589
Enrollment
60
Registered
2021-04-01
Start date
2021-04-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

Saga University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Medical Students

Exclusion criteria

Exclusion criteria: Person who had a history of COVID-19

Design outcomes

Primary

MeasureTime frame
Antibody Local reaction

Countries

Japan

Contacts

Public ContactMegumi Hara

Saga university Preventive medicine

harameg@cc.saga-u.ac.jp0952-34-2289

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026